SEC Form 4 · accession 0001209191-17-018801
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bridget A Martell
Officer — Chief Medical Officer
Period of report
Mar 3, 2017
Accepted (ET)
Mar 7, 2017 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 3, 2017 | A | 15,500 | $0.00 | A | 15,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $5.15 | Mar 3, 2017 | A | 74,900 | A | — | Mar 3, 2024 | Common Stock; $0.01 par value per share | 74,900 | 74,900 | D |
Explanation of responses
- F1This Restricted Stock Unit Award shall vest 25% on each anniversary of the date of grant over 4 years.
- F2The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant.